Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
283
-
Total 13F shares, excl. options
-
115M
-
Shares change
-
+6.26M
-
Total reported value, excl. options
-
$3.32B
-
Value change
-
+$214M
-
Put/Call ratio
-
2.46
-
Number of buys
-
148
-
Number of sells
-
-126
-
Price
-
$28.88
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2024
357 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2024.
Guardant Health, Inc. - Common Stock (GH) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 115M shares
of 124M outstanding shares and own 92.74% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.6M shares), BlackRock Inc. (11.2M shares), BAILLIE GIFFORD & CO (6.09M shares), Deep Track Capital, LP (4.5M shares), Capital International Investors (4.47M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.76M shares), Temasek Holdings (Private) Ltd (3.75M shares), WELLINGTON MANAGEMENT GROUP LLP (3.51M shares), CITADEL ADVISORS LLC (3.29M shares), and UBS ASSET MANAGEMENT AMERICAS LLC (3.23M shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.